1-2 of 2
Helen Melzer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab Maintenance Significantly Prolongs Event Free (EFS) and Progression Free Survival (PFS) In Male Patients With Aggressive B-Cell Lymphoma In The NHL13 Study

Ulrich Jaeger, Marek Trneny, MD, Ph.D., Helen Melzer, Michael Praxmarer, Michael A. Fridrik, MD, Weerasak Nawarawong, MD, Dina Ben Yehuda, Biljana Mihaljevic, PhD, Osman Ilhan, MD, Prof, Veronika Ballova, MD, Michael Hedenus, MD, PhD, Liang-Tsai Hsiao, MD, Wing-Yan Au, MD, Josef Thaler, MD, Gerhard Weidinger, MD, Felix Keil, MD, Christian Dittrich, Cathrin Skrabs, Daniela Wolkersdorfer, Anton Klingler, Richard Greil, MD, David Goldstein
Journal: Blood
Blood (2013) 122 (21): 851.
https://doi.org/10.1182/blood.V122.21.851.851
Published: 2013
Journal Articles

Two-Monthly Rituximab Infusions Maintain Target Concentrations: Pharmacokinetic Data of the AGMT-NHL9 Maintenance Study in Patients with Follicular Lymphoma in Complete or Partial Remission.

Ulrich Jaeger, MD, Otto Krieger, MD, Georg Hopfinger, MD, Cathrin Skrabs, MD, Christine Einberger, Veronika Huter, MD, Hubert Hausmaninger, MD, Johannes Drach, MD, Markus Raderer, MD, Michael Woo, Pharm.D, Helen Melzer, PhD, Richard Greil, MD, Michael A Fridrik, MD
Journal: Blood
Blood (2008) 112 (11): 1997.
https://doi.org/10.1182/blood.V112.11.1997.1997
Published: 2008